Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Chromanylsulfonyl(thio)ureas in early development at Hoechst Marion Roussel

Jan. 8, 1999

CNI-1493 attenuates hemodynamic and cytokine responses to LPS in rats

Jan. 7, 1999

S-19777: novel ET antagonist of microbial origin

Jan. 7, 1999

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Vascular-selective potassium channel openers designed at Kanebo

Dec. 30, 1998

U.S. patent improves proprietary position of Alexion in C5 complement inhibition

Dec. 30, 1998

FDA gives go-ahead for first human study of VEGF-2 gene therapy

Dec. 30, 1998

Myocardial protective effects of JTV-519 demonstrated in isolated rat hearts

Dec. 30, 1998

Cardiovascular and Renal Drugs Advisory Committee meets in late January to discuss two NDAs

Dec. 29, 1998

Knoll and Hoechst Marion Roussel to codevelop treatment for CHF and hypertension

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.